StockData
Obsidian Therapeutics, Inc. logo

Obsidian Therapeutics, Inc. (OBX) stock

OBXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$12.00−0.15 (-1.23%)

Close on Nov 20, 2026Market cap $741.28MP/E –Yield –

Key statistics

Valuation at the latest close; fundamentals over fiscal , balances at Sep 30, 2026

Valuation

Market cap
$741.28M
P/E ratio
–
Price to sales
–
Price to book
2.31
Dividend yield
–
Free cash flow yield
–

Fundamentals

Book value per share
$7.81
Diluted shares
41M

Trading

Previous close
$12.15
Open
$12.01
Day's range
$11.76 – $12.30
Volume
336,498
Average volume (20 days)
598,829
RSI (14 days)
43.2
Relative volume
0.81×

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 20, 2026. The S&P 500 is measured by the SPY fund.

PeriodOBXS&P 500DifferenceOBX per yearS&P 500 per year
1 month-9.4%-10.3%+0.9 pts
3 months-40.6%-9.3%−31.2 pts

Two years at a glance

Fiscal years 2024 to 2025, USD

Reported period

Press releases

Releases Obsidian Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K

Obsidian Therapeutics stock: common questions

What is Obsidian Therapeutics's stock price?

OBX closed at $12.00 on Nov 20, 2026, down 1.23% on the day.

What is Obsidian Therapeutics's market cap?

Obsidian Therapeutics was worth $741.28M at the close on Nov 20, 2026: the share price times the diluted shares outstanding.

Does Obsidian Therapeutics pay a dividend?

No. Obsidian Therapeutics has not paid a cash dividend over the last twelve months.

How many OBX shares are sold short?

1M shares were sold short at the latest FINRA report, 1.92% of the float, or 3.9 days of average trading volume.

Who are Obsidian Therapeutics's competitors?

Companies most similar to Obsidian Therapeutics by business, industry and size include LLY, JNJ, ABBV, MRK, AZN.

See a number that looks wrong?